Chemical probes and inhibitors of bromodomains outside the BET family
In the last five years, the development of inhibitors of bromodomains has emerged as an area of intensive worldwide research. Emerging evidence has implicated a number of non-BET bromodomains in the onset and progression of diseases such as cancer, HIV infection and inflammation. The development and...
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Journal article |
| Publié: |
Royal Society of Chemistry
2016
|